- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Can certain green vegetables help manage IBD? - Video
|
Overview
In a recent review published in the journal Current Developments in Nutrition, researchers assessed the therapeutic potential of cruciferous vegetables and their bioactive compounds in managing inflammatory bowel disease (IBD) using in vitro, in vivo, and clinical models.
Cruciferous veggies like broccoli and cabbage are packed with nutrients and special compounds called glucosinolates (GSLs). When we eat these veggies, an enzyme called myrosinase converts GSLs into isothiocyanates (ITCs). These ITCs have been studied for their ability to reduce inflammation and oxidative stress, which are important factors in inflammatory bowel disease (IBD). These vegetables have more helpful compounds like flavonoids and polyphenols. Together, these compounds not only fight inflammation and oxidative stress but also make the gut stronger and balance the gut bacteria, thus helping ease symptoms of IBD.
Research has highlighted the therapeutic potential of cruciferous vegetables in inflammatory bowel disease (IBD). In vitro studies reveal their anti-inflammatory properties, inhibiting key pathways in immune cell-mediated inflammation, while their antioxidant effects combat oxidative stress, a major contributor to IBD. Animal studies support these findings, showing that diets rich in cruciferous vegetables alleviate IBD symptoms, improve gut microbiota composition, increase short-chain fatty acid production, and enhance intestinal barrier integrity.
In experiments involving mice, feeding them broccoli extracts rich in SFN led to lower levels of inflammatory markers like TNF-alpha and IL-6. Additionally, it increased the levels of protective proteins in the gut lining, like ZO-1. This suggests that SFN not only reduces inflammation but also strengthens the gut lining, which is often weakened in people with IBD.
Additionally, future research aim to understand the individualized responses to cruciferous vegetable intake in different subpopulations of IBD patients. This could help tailor dietary recommendations to enhance individual patient outcomes and develop personalized nutritional therapies that are both effective and manageable over the long term.
Reference: TE Alaba, J.M. Holman, S.L. Ishaq, et al, Current knowledge on the preparation and benefits of cruciferous vegetables as relates to in vitro, in vivo, and clinical models of Inflammatory Bowel Disease., Current Developments in Nutrition, DOI - 10.1016/ j.cdnut.2024.102160, https://cdn.nutrition.org/article/S2475-2991(24)00094-5/fulltext
Speakers
Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.